CD47 and small cell lung carcinoma: In patients with SCLC, the combination of radiotherapy and CD47 blockade may improve treatment of primary tumors or metastases treated directly with radiotherapy but could also reduce the growth of distant lesions in patients with widespread metastatic disease that are difficult to irradiate in total14.